Stephen P. Ewald
Net Worth
Last updated:
What is Stephen P. Ewald net worth?
The estimated net worth of Mr. Stephen P. Ewald is at least $21,113,585 as of 1 Mar 2024. He owns shares worth $6,296,952 as insider, has earned $11,291,273 from insider trading and has received compensation worth at least $3,525,360 in Medpace Holdings, Inc..
What is the salary of Stephen P. Ewald?
Mr. Stephen P. Ewald salary is $587,560 per year as Chief Compliance Officer, Gen. Counsel & Corporation Sec. in Medpace Holdings, Inc..
How old is Stephen P. Ewald?
Mr. Stephen P. Ewald is 56 years old, born in 1969.
What stocks does Stephen P. Ewald currently own?
As insider, Mr. Stephen P. Ewald owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Medpace Holdings, Inc. (MEDP) | Chief Compliance Officer, Gen. Counsel & Corporation Sec. | 13,341 | $472 | $6,296,952 |
What does Medpace Holdings, Inc. do?
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Stephen P. Ewald insider trading
Medpace Holdings, Inc.
Mr. Stephen P. Ewald has made 12 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 350 units of MEDP stock worth $140,277 on 1 Mar 2024.
The largest trade he's ever made was exercising 21,850 units of MEDP stock on 27 Jul 2023. As of 1 Mar 2024 he still owns at least 13,341 units of MEDP stock.
Medpace Holdings key executives
Medpace Holdings, Inc. executives and other stock owners filed with the SEC:
- Dr. August James Troendle M.D. (69) Chairman & Chief Executive Officer
- Mr. Jesse J. Geiger BBA, CPA (51) Pres
- Mr. Stephen P. Ewald (56) Chief Compliance Officer, Gen. Counsel & Corporation Sec.
- Ms. Susan E. Burwig (62) Executive Vice President of Operations